In a Patient with clinical signs of Asthma which of the following tests will confirm the diagnosis
## **Core Concept**
Asthma is a chronic inflammatory disease of the airways characterized by recurring episodes of reversible airflow obstruction, bronchospasm, and increased airway responsiveness to various stimuli. The diagnosis of asthma involves a combination of clinical evaluation, spirometry, and other tests to assess lung function and rule out other conditions.
## **Why the Correct Answer is Right**
The correct answer, **D. Peak Expiratory Flow Rate (PEFR) monitoring or Spirometry**, confirms the diagnosis of asthma by demonstrating reversible airflow obstruction. Spirometry, particularly, is a crucial diagnostic tool that measures the volume and/or flow of air that can be inhaled and exhaled by the lungs. It can show a reduced Forced Expiratory Volume in 1 second (FEV1) and a normal or increased Forced Vital Capacity (FVC), indicating an obstructive pattern. Reversibility is confirmed if there is an increase in FEV1 by 12% and 200 ml after bronchodilator administration. PEFR monitoring can also show variability in lung function over time.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Chest X-ray is not used to diagnose asthma but can help rule out other conditions that may present with similar symptoms, such as pneumonia or pneumothorax. It is often normal in patients with asthma.
- **Option B:** Allergy testing can identify specific allergens that may trigger asthma symptoms but does not confirm the diagnosis of asthma itself. Many patients with asthma have allergies, but not all allergic individuals have asthma.
- **Option C:** Arterial Blood Gas (ABG) analysis can provide information on the level of oxygenation and acid-base status but does not specifically diagnose asthma. It may show hypoxemia during severe asthma exacerbations but is not diagnostic.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that asthma diagnosis requires demonstration of reversible airflow limitation. Spirometry before and after bronchodilator administration is the gold standard for confirming reversible airflow obstruction. A significant improvement in FEV1 after bronchodilator (β₯12% and 200 ml) supports the diagnosis of asthma.
## **Correct Answer:** D. Peak Expiratory Flow Rate (PEFR) monitoring or Spirometry